On Friday, Corvus Pharmaceuticals Inc (CRVS) stock saw a modest uptick, ending the day at $7.21 which represents no change from the prior close of of $7.21. The stock opened at $7.11 and touched a low ...

StockNews.com upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a sell rating to a hold rating in a ...

Scotiabank started coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) in a research report sent to investors on Wednesday, MarketBeat.com reports. The firm issued a sector ...

Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...

Terry Duffy is pulling all stops to thwart Howard Lutnick’s plan to launch rival contracts that clear in London.

Without a loan from the German government and the matching funds from the State of Bavaria, Lilium N.V. (NASDAQ:LILM) will ...

Vertex's diverse pipeline positions it for a growth, despite challenges in launching new drugs like Casgevy and suzetrigine.

TSMC's report overnight "confirms our view that there is no slowdown to the AI growth story, which should drive continued outperformance" for shares of Nvidia, Broadcom, AMD, Micron and Marvell ...

Closely-watched cases could have implications for areas of corporate law that have come up repeatedly in attorneys' ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from ...